Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Repaglinide> ?p ?o. }
- Repaglinide abstract "Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. It is sold by Novo Nordisk under the name of Prandin in the U.S., GlucoNorm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.".
- Repaglinide atcPrefix "A10".
- Repaglinide atcSuffix "BX02".
- Repaglinide bioavailability "56.0".
- Repaglinide casNumber "135062-02-1".
- Repaglinide drugbank "DB00912".
- Repaglinide fdaUniiCode "668Z8C33LU".
- Repaglinide iupacName "(S)-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid".
- Repaglinide pubchem "65981".
- Repaglinide thumbnail Repaglinide.svg?width=300.
- Repaglinide wikiPageExternalLink .piw?Docid=05312924&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%2Fnetahtml%2Fsearch-adv.htm%2526r%3D1%2526p%3D1%2526f%3DG%2526l%3D50%2526d%3Dptxt%2526S1%3D5,312,924.WKU.%2526OS%3Dpn%2F5,312,924%2526RS%3DPN%2F5,312,924&PageNum=&Rtype=&SectionNum=&idkey=78F2DB31DFC3.
- Repaglinide wikiPageExternalLink .piw?Docid=RE037035&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%2Fnetahtml%2Fsearch-adv.htm%2526r%3D1%2526p%3D1%2526f%3DG%2526l%3D50%2526d%3Dptxt%2526S1%3DRE37035.WKU.%2526OS%3Dpn%2FRE37035%2526RS%3DPN%2FRE37035&PageNum=&Rtype=&SectionNum=&idkey=D352419F1A91.
- Repaglinide wikiPageExternalLink .piw?Docid=06143769&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%2Fnetahtml%2Fsearch-adv.htm%2526r%3D1%2526p%3D1%2526f%3DG%2526l%3D50%2526d%3Dptxt%2526S1%3D6,143,769.WKU.%2526OS%3Dpn%2F6,143,769%2526RS%3DPN%2F6,143,769&PageNum=&Rtype=&SectionNum=&idkey=70E08B986900.
- Repaglinide wikiPageExternalLink .piw?Docid=06677358&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%2Fnetahtml%2Fsearch-adv.htm%2526r%3D1%2526p%3D1%2526f%3DG%2526l%3D50%2526d%3Dptxt%2526S1%3D6,677,358.WKU.%2526OS%3Dpn%2F6,677,358%2526RS%3DPN%2F6,677,358&PageNum=&Rtype=&SectionNum=&idkey=FFC461309CD5.
- Repaglinide wikiPageExternalLink 020741s034lbl.pdf.
- Repaglinide wikiPageExternalLink www.prandin.com.
- Repaglinide wikiPageID "3776525".
- Repaglinide wikiPageRevisionID "606303786".
- Repaglinide atcPrefix "A10".
- Repaglinide atcSuffix "BX02".
- Repaglinide bioavailability "56.0".
- Repaglinide c "27".
- Repaglinide casNumber "135062".
- Repaglinide chembl "1272".
- Repaglinide chemspiderid "59377".
- Repaglinide drugbank "DB00912".
- Repaglinide eliminationHalfLife "3600.0".
- Repaglinide excretion "Fecal and renal".
- Repaglinide h "36".
- Repaglinide hasPhotoCollection Repaglinide.
- Repaglinide image "Repaglinide ball-and-stick.png".
- Repaglinide inchi "1".
- Repaglinide inchikey "FAEKWTJYAYMJKF-QHCPKHFHBW".
- Repaglinide iupacName "--2-ethoxy-4-[2--2-oxoethyl]benzoic acid".
- Repaglinide kegg "D00594".
- Repaglinide legalUk "POM".
- Repaglinide legalUs "Rx-only".
- Repaglinide licenceEu "Novonorm".
- Repaglinide licenceUs "Prandin".
- Repaglinide medlineplus "a600010".
- Repaglinide metabolism "Hepatic oxidation and glucuronidation".
- Repaglinide molecularWeight "452.586".
- Repaglinide n "2".
- Repaglinide o "4".
- Repaglinide pregnancyCategory "C ( )".
- Repaglinide proteinBound ">98%".
- Repaglinide pubchem "65981".
- Repaglinide routesOfAdministration "Oral".
- Repaglinide smiles "O=Cc1cccCCN[C@H]CCC".
- Repaglinide stdinchi "1".
- Repaglinide stdinchikey "FAEKWTJYAYMJKF-QHCPKHFHSA-N".
- Repaglinide tradename "Prandin".
- Repaglinide unii "668".
- Repaglinide verifiedrevid "464380887".
- Repaglinide subject Category:Acetamides.
- Repaglinide subject Category:Benzoic_acids.
- Repaglinide subject Category:Meglitinides.
- Repaglinide subject Category:Phenol_ethers.
- Repaglinide subject Category:Piperidines.
- Repaglinide type Abstraction100002137.
- Repaglinide type Acetamide114711197.
- Repaglinide type Acetamides.
- Repaglinide type Acid114607521.
- Repaglinide type Amide114724264.
- Repaglinide type BenzoicAcid114775321.
- Repaglinide type BenzoicAcids.
- Repaglinide type CarboxylicAcid114739360.
- Repaglinide type Chemical114806838.
- Repaglinide type Compound114818238.
- Repaglinide type Element114840755.
- Repaglinide type Material114580897.
- Repaglinide type Matter100020827.
- Repaglinide type OrganicCompound114727670.
- Repaglinide type Part113809207.
- Repaglinide type PhenolEthers.
- Repaglinide type PhysicalEntity100001930.
- Repaglinide type Quintessence114847103.
- Repaglinide type Relation100031921.
- Repaglinide type Substance100019613.
- Repaglinide type Drug.
- Repaglinide type DrugProduct.
- Repaglinide type FunctionalSubstance.
- Repaglinide comment "Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. It is sold by Novo Nordisk under the name of Prandin in the U.S., GlucoNorm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.".
- Repaglinide label "Repaglinida".
- Repaglinide label "Repaglinide".
- Repaglinide label "Repaglinide".
- Repaglinide label "Repaglinide".
- Repaglinide label "Répaglinide".
- Repaglinide label "瑞格列奈".
- Repaglinide sameAs Repaglinida.
- Repaglinide sameAs Répaglinide.
- Repaglinide sameAs Repaglinide.
- Repaglinide sameAs Repaglinide.
- Repaglinide sameAs m.09_f8g.
- Repaglinide sameAs Q2195995.
- Repaglinide sameAs Q2195995.
- Repaglinide sameAs repaglinide.
- Repaglinide sameAs DB00912.
- Repaglinide sameAs 4547.
- Repaglinide sameAs Repaglinide.